PV > MDS/MPN > ET). We observed stronger association between CD105-MVD and VEGF expression, fibrosis, and JAK2-V617F mutant allele burden, compared to CD34-MVD. MVD was strongly increased in MPN with high JAK2-V617F mutant allele burden. Our study highlights the importance of newly formed CD105+ vessels in the bone marrow of MPN patients, and indicates that assessment of CD105-MVD better reflects angiogenic activity in MPN. In addition, it provides evidence that despite the fact that angiogenesis is generally independent of the JAK2-V617F status in MPN, new vessel formation might be linked to Jak2 effects in some cases with high JAK2-V617F mutant allele burden. © 2009 Blackwell Publishing Ltd.
CITATION STYLE
Medinger, M., Skoda, R., Gratwohl, A., Theocharides, A., Buser, A., Heim, D., … Tzankov, A. (2009). Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: Correlation with clinical parameters and JAK2-V617F mutational status. British Journal of Haematology, 146(2), 150–157. https://doi.org/10.1111/j.1365-2141.2009.07726.x
Mendeley helps you to discover research relevant for your work.